Stage IIIB Breast Cancer Active Not Recruiting Phase 3 Trials for Entinostat (DB11841)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02115282Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticTreatment